Technology

The Cardius 3 XPO triple-head camera features fourth- generation High Definition Solid-State Detectors (HDSD) that offer up to a 38 percent greater image acquisition efficiency for cardiac SPECT over dual-head systems and a patient positioning system that permits imaging patients weighing up to 500 pounds.

Home March 22, 2007
Home
Technology

Ideal for basic 12-lead resting ECG analysis, the MAC 3500 electrocardiograph unit delivers technology to help clinicians improve reliability and accuracy in cardiac assessments, while also helping to increase productivity and efficiency.

Home March 22, 2007
Home
Technology

Cardiac Science Corp. has launched HeartCentrix, a software solution that enables its diagnostic stress, Holter and electrocardiography devices to communicate seamlessly with physician office-based electronic medical record (EMR) systems.

Home March 22, 2007
Home
Technology

St. Jude Medical Inc. says it has received FDA approval of a new cardiac rhythm management device designed to help physicians manage heart failure (HF) patients, including patients who have or may develop atrial fibrillation (AF).

Home March 22, 2007
Home
Technology

A new MRI monitor to complement the Maglife product line, the Maglife light makes MRI monitoring within reach of virtually every MRI Center. It can handle all monitoring needs and is compatible with MRI scanners up to 3T.

Home March 22, 2007
Home
Technology

When used in conjunction with the ev3 embolic protection device, ev3’s PROTÉGÉ RX Carotid Stent has been FDA cleared for the treatment of carotid artery disease in patients who are at high-risk for adverse events from carotid artery surgery. The cleatance was supported by the CREATE (Carotid Revascularization with ev3 Inc.

Home March 22, 2007
Home
Technology

VIASYS Healthcare is showcasing the launch of the MasterScreen CPX, a product that combines 40 years of CPET experience into a compact unit.

Home March 22, 2007
Home
Technology

Pfizer says the FDA has approved the company’s Lipitor (atorvastatin calcium) Tablets to reduce the risk of nonfatal heart attacks, fatal and non-fatal strokes, certain types of heart surgery, hospitalization for heart failure, and chest pain in patients with heart disease — making Lipitor the first cholesterol-lowering medication to receive FDA approval for the reduction of the risk of hospit

Home March 22, 2007
Home
Technology

Diagnosoft HARP is software that assists physicians in the analysis of magnetic resonance (MR) images by providing quantitative measurements and visualization of regional heart function. Based on technology from Johns Hopkins University, it’s the first FDA-cleared software designed for the analysis of tagged MR images.

Home March 22, 2007
Home
Technology

The NICO2 Respiratory Profile Monitor is designed to monitor the patient side of the breathing circuit. NICO2 goes beyond conventional capnography to measure breath-by-breath volumetric CO2 and takes the guesswork out of ventilation management from setup to weaning.

Home March 22, 2007
Home
Feature | Jeffrey J. Fine and Timothy W. Attebery

Coronary computed tomography angiography (CCTA) has recently made significant technological and clinical advances. Submillimeter slice thickness, increased detectors and reduced acquisition times have multiplied the number of patients that can benefit from noninvasive diagnostic imaging.

Home March 22, 2007
Home
News

March 22 2007 — ZOLL Medical Corp announced today it received FDA clearance to market and sell the ZOLL M Series with ...

Home March 21, 2007
Home
News

March 22, 2007 — St. Jude Medical Inc. says it has received FDA approval of a new cardiac rhythm management device ...

Home March 21, 2007
Home
Feature | Larry Sieb

Cardiac exams represent only about five percent of all CT procedures, but cardiac CT continues to generate the most interest at manufacturers’ exhibits as seen at the 2006 RSNA Annual Scientific Meeting. The fascination with Cardiovascular Computed Tomography (CVCT) remains high even though full reimbursement is not expected to occur until 2009, according to industry observers at RSNA.

Home March 21, 2007
Home
News

March 22, 2007 — Evalve, Inc., a privately held medical device company, has announced the FDA has approved a registry of up to 70 patients who are at high risk of mortality from surgical treatment for mitral regurgitation (MR) as part of its ongoing pivotal EVEREST Study (Endovascular Valve Edge-to-Edge REpair STudy).

Home March 21, 2007
Home
Subscribe Now